Wing Tai Properties preempts losses for H1

But the company assured that its cash flow remains sound.

Wing Tai Properties expects a consolidated loss for the first six months of the year-end on 30 June, the company announced in an SGX filing.

The group said that its business in 2020 has so far been impacted by the COVID-19 outbreak and the weakening local and world economy.

The preliminary estimation was made mainly due to the possibility of an adverse change in fair value of the group’s investment properties, and the possibility of an adverse change in fair value of financial instruments, the group said.

However, Wing Tai further noted that the two factors leading to the loss are all non-cash items and will not have an impact on the cash flow of the group. It also assured that its overall financial, business and trading positions remain healthy.

Wing Tai will release its consolidated H1 results in August.

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare